Trial of Vision Therapy for Intermittent Exotropia

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Southern California College of Optometry at Marshall B. Ketchum University
Study ID
NCT04487249
Status
Recruiting

Conditions

  • Intermittent Exotropia

Eligibility Criteria

Sex
ALL
Age
8 Years - 16 Years
Healthy Volunteers
Not accepted

Interventions

  • Vision Therapy — OTHER
    20 consecutive weeks of office-based vision therapy with home therapy that aim to improve the participant's vergence skills, accommodative skills, and sensory fusion.

Study Details

The main objective of this randomized trial comparing vision therapy to observation is to determine the short-term effectiveness of vision therapy on distance intermittent exotropia control. The results will help determine whether to proceed to a full-scale, long-term randomized trial.

Key Dates

Start date
Oct 1, 2021
Status verified
Mar 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
58 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Vision Therapy
    Participants will receive 20 consecutive weeks of office-based vision therapy with home therapy.
  • No Intervention: Observation
    Participants will receive no treatment for IXT is received during the study unless one of the deterioration criteria is met.

Primary Outcome Measure

Mean Distance Control Score [ Time Frame: 21 weeks ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
University of Alabama in BirminghamBirminghamAlabama35294
Kristine Hopkins, OD, MSPH
205-996-1678
Southern California College of Optometry at Marshall B. Ketchum UniversityFullertonCalifornia92831
Angela Chen, OD, MS
714-463-7569
Stanford UniversityStanfordCalifornia94305
Tawna Roberts, OD, PhD
650-723-1143
Ohio State UniversityColumbusOhio43210
Ann Morrison, OD, MS
614-247-0010
Salus UniversityPhiladelphiaPennsylvania19141
Erin Jenewein, OD, MS
215-276-6053
Southern College of OptometryMemphisTennessee38104
Marie Bodack, OD
901-722-3349

Find similar trials in Birmingham, AL

Related Studies